Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pregnant Woman With Single Pregnancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00000879
What this trial is testing

The Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableStudy completedNCT04812197
What this trial is testing

Microbial Diversity Between Inflamed and Non-inflamed Skin of Patients With Immune Checkpoint Inhibitor-Induced Dermatitis

Who this might be right for
Genito-Urinary Neoplasm
City of Hope Medical Center 2
Not applicableStudy completedNCT04976010
What this trial is testing

Single Cell Leukocyte Landscapes and Cardiovascular Risk in Children With Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseasesCardiovascular DiseasesMicrobial Colonization+1 more
Charite University, Berlin, Germany 38
Large-scale testing (Phase 3)Active Not RecruitingNCT04579224
What this trial is testing

Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer

Who this might be right for
Metastatic Bladder Urothelial CarcinomaMetastatic Urothelial CarcinomaRefractory Bladder Urothelial Carcinoma+2 more
National Cancer Institute (NCI) 184
Early research (Phase 1)WithdrawnNCT01832103
What this trial is testing

The Pharmacokinetics of MK-7145 Following Single Dose Administration in Participants With Moderate Renal Insufficiency (MK-7145-018)

Who this might be right for
Renal Insufficiency
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Study completedNCT04341883
What this trial is testing

Study of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer

Who this might be right for
Recurrent Cervical Cancer
Sun Yat-sen University 27
Testing effectiveness (Phase 2)Looking for participantsNCT07718854
What this trial is testing

Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer

Who this might be right for
Ovarian Clear Cell CarcinomaMetastatic Ovarian CancerRecurrent Ovarian Clear Cell Adenocarcinoma
Tufts Medical Center 50
Early research (Phase 1)Study completedNCT02437422
What this trial is testing

Study to Assess the Safety and Impact on Humoral Sensitization of SANGUINATE in Patients With End Stage Renal Disease

Who this might be right for
Renal Insufficiency, Chronic
Prolong Pharmaceuticals 5
Early research (Phase 1)Active Not RecruitingNCT06253845
What this trial is testing

Study of CG0070 After Transurethral Resection in Patients With IR NMIBC

Who this might be right for
Non-muscle Invasive Bladder Cancer
H. Lee Moffitt Cancer Center and Research Institute 20
Not applicableUnknownNCT03273881
What this trial is testing

Intrapartum Glucose and Insulin Compared to Glucose Alone in Diabetic Women

Who this might be right for
Obstetric LaborPregnancy in Diabetics
HaEmek Medical Center, Israel 200
Early research (Phase 1)Study completedNCT00935831
What this trial is testing

Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

Who this might be right for
Kidney Disease
GlaxoSmithKline 12
Testing effectiveness (Phase 2)Looking for participantsNCT06354231
What this trial is testing

DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC

Who this might be right for
Renal InsufficiencyUpper Urinary Tract Urothelial CarcinomaSolitary Kidney
Fudan University 20
Early research (Phase 1)Study completedNCT02586051
What this trial is testing

Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation

Who this might be right for
Kidney Failure, Chronic
Hoffmann-La Roche 24
Not applicableUnknownNCT03463772
What this trial is testing

IVM Versus Standard IVF in Infertile Patients Diagnosed With PCOS

Who this might be right for
PCOS
Jie Qiao 350
Testing effectiveness (Phase 2)Study completedNCT01336972
What this trial is testing

Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Otsuka Pharmaceutical Development & Commercialization, Inc. 29
Not applicableLooking for participantsNCT06962345
What this trial is testing

Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.

Who this might be right for
Vulvar AtrophyVulvovaginal Signs and SymptomsGenitourinary Syndrome of Menopause+7 more
Mucosa Innovations, S.L. 80
Early research (Phase 1)Not Yet RecruitingNCT07181265
What this trial is testing

Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Jemincare 48
Large-scale testing (Phase 3)Looking for participantsNCT06994845
What this trial is testing

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

Who this might be right for
Primary Immunoglobulin A Nephropathy (IgAN)
Novartis Pharmaceuticals 31
Post-approval studies (Phase 4)Looking for participantsNCT04279457
What this trial is testing

Single-Center Prospective Study to Investigate the Difference in the Incidence of Contrast-Induced Nephropathy in High-Risk Patients With the Use of the Dye-Vert Plus System

Who this might be right for
AKI (Acute Kidney Injury) Due to Trauma
CAMC Health System 1,802
Early research (Phase 1)Study completedNCT02852239
What this trial is testing

Pharmacokinetics of Dabrafenib in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 22
Next Page